Artículos Científicos en Ingles

Artículos Científicos RSS AJKD

326 Lupus Nephritis With Superimposed Necrotizing and Crescentic PR-3 Antineutrophil Cytoplasmatic Antibody

Este artículo no posee resumen

315 A Case of Immune Checkpoint Inhibitor Associated PLA2R Membranous Nephropathy and Concurrent Acute Interstitial Nephritis Treated With Anti-CD20 Therapy

Este artículo no posee resumen

314 Collagenofibrotic Glomerulopathy

Este artículo no posee resumen

303 Success Story of a Challenging Case of Refractory Lupus Nephritis

Este artículo no posee resumen

304 A Case of Podocytic Infolding Glomerulopathy: A Pattern of Injury

Este artículo no posee resumen

305 Trial in Progress: Voclosporin in Adolescents With Lupus Nephritis (VOCAL)

Este artículo no posee resumen

306 Enlight-LN: A Prospective Observational Registry of Patients Treated With Voclosporin for Lupus Nephritis in the United States

Este artículo no posee resumen

307 Pipeline Innovation in Glomerular Diseases

Este artículo no posee resumen

308 Primary Membranous Nephropathy Shortly After COVID-19 Vaccination

Este artículo no posee resumen

309 Simultaneous Presence of MPO-ANCA Vasculitis and A Lymphoplasmacytic Lymphoma Isolated to the Bowman’s Capsule Requiring a Multidisciplinary Approach to Treatment

Este artículo no posee resumen

310 Treatment Considerations of Anti-GBM and ANCA Overlap Syndrome: First Do No Harm

Este artículo no posee resumen

311 A Case of Glomerulonephritis With Dual Seropositive Autoantibodies

Este artículo no posee resumen

312 Relevance of Anti-PLA2R Levels in Therapy Decision and Prediction of Therapy Outcome Using Cyclophosphamide and Steroids Treatment in Patients With Membranous Nephropathy

Este artículo no posee resumen

313 Serodiagnosis of Anti-Glomerular Basement Membrane Disease Using a Newly Developed Chemiluminescence Immunoassay

Este artículo no posee resumen

327 Zetomipzomib is Associated With Clinically Meaningful Reduction of Proteinuria in LN Class III/IV With or Without Class V: Post-Hoc Analysis From the Open-Label MISSION Phase 2 Study

Este artículo no posee resumen

Páginas